TuHURA Biosciences, Inc.
HURA
$2.04
-$0.08-3.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.14M | 2.30M | 2.34M | 1.76M | 1.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.76M | 7.53M | 8.39M | 6.73M | 6.79M |
| Operating Income | -8.76M | -7.53M | -8.39M | -6.73M | -6.79M |
| Income Before Tax | -9.22M | -7.54M | -6.76M | -7.10M | -9.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.22M | -7.54M | -6.76M | -7.10M | -9.52M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.22M | -7.54M | -6.76M | -7.10M | -9.52M |
| EBIT | -8.76M | -7.53M | -8.39M | -6.73M | -6.79M |
| EBITDA | -8.74M | -7.51M | -8.37M | -6.71M | -6.78M |
| EPS Basic | -0.14 | -0.13 | -0.13 | -0.14 | -0.21 |
| Normalized Basic EPS | -0.09 | -0.08 | -0.10 | -0.08 | -0.09 |
| EPS Diluted | -0.14 | -0.13 | -0.13 | -0.14 | -0.21 |
| Normalized Diluted EPS | -0.09 | -0.08 | -0.10 | -0.08 | -0.09 |
| Average Basic Shares Outstanding | 63.96M | 60.01M | 53.00M | 50.67M | 44.56M |
| Average Diluted Shares Outstanding | 63.96M | 60.01M | 53.00M | 50.67M | 44.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.02% | -0.03% | -0.03% | -0.03% | -0.02% |